Aggression and Bedridden
Summary:
Bedridden is found among people with Aggression, especially for people who are female, 60+ old.
The study analyzes which people have Bedridden with Aggression. It is created by eHealthMe based on reports of 15 people who have Aggression from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Aggression?
Aggression is found to be associated with 1,617 drugs and 1,954 conditions by eHealthMe. Check the latest studies of Aggression.
What is Bedridden?
Bedridden is found to be associated with 956 drugs and 1,094 conditions by eHealthMe. Check the latest studies of Bedridden.
15 people who have Aggression and Bedridden are studied.

Gender of people who have Aggression and experienced Bedridden *:
- female: 86.67 %
- male: 13.33 %
Age of people who have Aggression and experienced Bedridden *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 26.67 %
- 50-59: 20.0 %
- 60+: 53.33 %
Common co-existing conditions for these people *:
Common drugs taken by these people *:
Common symptoms for these people *:
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Bedridden?
- Check whether Bedridden is associated with a drug or a condition (FREE)Related studies:
Treatments, associated drugs and conditions:
- Aggression (65,309 reports)
- Bedridden (14,887 reports)
All the drugs that are associated with Bedridden:
- Bedridden (956 drugs)
All the conditions that are associated with Bedridden:
- Bedridden (1,094 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Bedridden and Aggression, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Risperidone and Obesity for Boys aged 10-19 - now
- Risperidone and Lose Weight for Boys aged 10-19 - a second ago
- Risperidone and Overweight for Boys aged 10-19 - a second ago
- Risperidone and Weight Loss - Intentional for Boys aged 10-19 - a second ago
- Risperidone and Losing Weight for Boys aged 10-19 - a second ago
- Risperidone and Weight Control for Boys aged 10-19 - 2 seconds ago
- Could Amoxicillin cause Mediastinitis? - 16 seconds ago
- Drug interactions of Ticagrelor and Repatha - 21 seconds ago
- Doxycycline Hyclate and Clonazepam drug interactions for women aged 50-59 - 23 seconds ago
- Hearing Impaired and drugs of ingredients of acetaminophen; hydrocodone bitartrate - 25 seconds ago